GETINGE Share Holder Equity 2016-2023 | GNGBY
GETINGE share holder equity from 2016 to 2023. Share holder equity can be defined as the sum of preferred and common equity items
| GETINGE Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2022 | $3,018 |
| 2021 | $2,936 |
| 2020 | $2,342 |
| 2019 | $2,219 |
| 2018 | $2,262 |
| 2017 | $2,323 |
| 2016 | $2,445 |
| 2015 | $2,324 |
| GETINGE Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2023-09-30 | $2,961 |
| 2023-06-30 | $2,974 |
| 2023-03-31 | $2,969 |
| 2022-12-31 | $3,018 |
| 2022-09-30 | $2,933 |
| 2022-06-30 | $2,873 |
| 2022-03-31 | $2,841 |
| 2021-12-31 | $2,936 |
| 2021-09-30 | $2,781 |
| 2021-06-30 | $2,707 |
| 2021-03-31 | $2,764 |
| 2020-12-31 | $2,342 |
| 2020-09-30 | $2,482 |
| 2020-06-30 | $2,200 |
| 2020-03-31 | $2,359 |
| 2019-12-31 | $2,219 |
| 2019-09-30 | $2,180 |
| 2019-06-30 | $2,121 |
| 2019-03-31 | $2,206 |
| 2018-12-31 | $2,262 |
| 2018-09-30 | $2,114 |
| 2018-06-30 | $2,387 |
| 2018-03-31 | $2,476 |
| 2017-12-31 | $2,323 |
| 2017-09-30 | $2,922 |
| 2017-06-30 | $2,279 |
| 2017-03-31 | $2,315 |
| 2016-12-31 | $2,445 |
| 2016-09-30 | $2,260 |
| 2016-06-30 | $2,311 |
| 2016-03-31 | $2,263 |
| 2015-12-31 | $2,324 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.000B | $3.000B |
| Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $127.298B | 15.97 |
| Cencora (COR) | United States | $44.302B | 17.27 |
| ICON (ICLR) | Ireland | $25.963B | 24.51 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| Avantor (AVTR) | United States | $16.975B | 24.99 |
| CochLear (CHEOY) | Australia | $14.527B | 0.00 |
| Revvity (RVTY) | United States | $13.602B | 23.86 |
| Viatris (VTRS) | United States | $13.074B | 3.91 |
| Natera (NTRA) | United States | $13.074B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.216B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.186B | 40.09 |
| Charles River Laboratories (CRL) | United States | $11.415B | 21.85 |
| Solventum (SOLV) | United States | $10.774B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.566B | 0.00 |
| HealthEquity (HQY) | United States | $6.796B | 50.78 |
| Organon (OGN) | United States | $5.606B | 5.32 |
| Doximity (DOCS) | United States | $5.229B | 36.40 |
| Bausch + Lomb (BLCO) | Canada | $5.150B | 20.63 |
| PACS (PACS) | United States | $4.236B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.283B | 30.03 |
| Sotera Health (SHC) | United States | $3.196B | 15.68 |
| Life Times (LTH) | United States | $3.040B | 31.85 |
| GoodRx Holdings (GDRX) | United States | $2.807B | 106.86 |
| Progyny (PGNY) | United States | $2.675B | 46.05 |
| NovoCure (NVCR) | Jersey | $2.366B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.230B | 8.84 |
| Agilon Health (AGL) | United States | $2.225B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.159B | 0.00 |
| Premier (PINC) | United States | $2.061B | 8.82 |
| BrightSpring Health Services (BTSG) | United States | $1.965B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.557B | 0.00 | |
| Alignment Healthcare (ALHC) | United States | $1.388B | 0.00 |
| Embecta (EMBC) | United States | $0.833B | 5.67 |
| CareDx (CDNA) | United States | $0.807B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.703B | 18.40 |
| Pediatrix Medical (MD) | United States | $0.651B | 6.91 |
| Auna S.A (AUNA) | Luxembourg | $0.645B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.585B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.536B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.503B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.448B | 0.00 |
| Enhabit (EHAB) | United States | $0.414B | 41.25 |
| ModivCare (MODV) | United States | $0.391B | 7.32 |
| MultiPlan (MPLN) | United States | $0.380B | 0.00 |
| Beauty Health (SKIN) | United States | $0.338B | 0.00 |
| LifeMD (LFMD) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.313B | 17.11 |
| Sharecare (SHCR) | United States | $0.310B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.277B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.270B | 0.00 |
| Biodesix (BDSX) | United States | $0.181B | 0.00 |
| So-Young (SY) | China | $0.122B | 41.00 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| NeueHealth (NEUE) | United States | $0.049B | 6.66 |
| Oncology Institute (TOI) | United States | $0.047B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| Nutex Health (NUTX) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.034B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.029B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.028B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.024B | 0.00 |
| DermTech (DMTK) | United States | $0.017B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| OpGen (OPGN) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |